With regard to the trading Tex the volume after both of the dips in February was quite dramatic. Almost as if insiders had submitted note conversion requests to the company and could finally buy without impacting the plan. Its also possible that there was shorting activity involved in those dips that needed to be covered. You gotta love Catalina. Knowing that all of this was coming she was willing to purchase her 10M shares at 3 cents after she scored the DED relationship with her old cronies. She was willing to fund the company at that level in exchange for being able to purchase such a large block of shares off market. Either way she is a big believer. Cat was willing to put down serious change while her peers paid peanuts for options and signed free deals to be the recipients of put options. Maybe that was her buy in price to become a family member. I see her running this show a few years down the road after the company is solidly launched and the old family members have made their money.
I agree with you about Verséa going public. It seems like that's what Biotech companies do. Build some products and sell to the big players.
I'm not sure if AXIM and Verséa could combine companies where everyone would be happy with their share. But the 2 companies might be stronger together.
I don't know anything about NPTX.
The Tarsus name came up from the reactions to LinkedIn posts.
News 
Market Data 
Discover 
